GlassScriptPhysician profile
Florian Gegaj
NPI 1205099660
$911.73
in general payments reported to CMS, 2019-2025
18 companies · $17.36 in 2025
The $17.36 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $405 · 2020: $108 · 2021: $79.03 · 2022: $149 · 2024: $154 · 2025: $17.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $170.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tosoh Bioscience, INC. | $169.00 | 2019 | |
| Edwards Lifesciences Corporation | $153.50 | 2024 | Sapien 3 Ultra Resilia |
| Novo Nordisk INC | $92.32 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $72.35 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $71.27 | 2019-2022 | |
| Amarin Pharma, INC. | $70.73 | 2019 | |
| Glaxosmithkline, LLC. | $45.74 | 2020-2021 | |
| Fidia Pharma USA INC. | $32.63 | 2022 | |
| Amgen INC. | $30.93 | 2019 | |
| Pfizer INC. | $28.12 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $28.12 | 2019 | |
| Arbor Pharmaceuticals, INC. | $22.78 | 2019-2021 | |
| Lilly USA, LLC | $19.07 | 2022 | |
| Sanofi Pasteur INC. | $17.36 | 2025 | |
| Eisai INC. | $15.26 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $14.93 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.90 | 2019 | |
| Esperion Therapeutics, INC. | $12.72 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Florian Gegaj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.